| Vol. 11.26 – 26 November, 2020 |
| |
|
|
| The clinical efficacy was evaluated based on glycemic control status and β cell function, as well as the daily insulin requirement in diabetic patients after receiving umbilical cord-derived stem cell-transplantation compared to baseline values. [Stem Cell Research & Therapy] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Blood and ovary tissue were collected and analyzed after various placenta -derived (PD)-MSC transplantation treatments in an ovariectomized rat model. Changes in the expression of folliculogenesis- and ovary regeneration-related genes induced by PD-MSC treatments were analyzed by qRT-PCR, Western blotting, and histological analysis. [Stem Cell Research & Therapy] |
|
|
|
| Cellular deregulation was assessed by measuring glutathione levels, basal calcium and intracellular calcium response under KCl stimulation, as well as the key parameters of proliferation, glial progenitor marker expression and migration. [Cellular and Molecular Neurobiology] |
|
|
|
| CXCR1 and CXCR2 were not detected on several clones of cord blood- endothelial colony-forming cell using different antibodies available, in contrast to well-known positive cells. [Stem Cell Reviews and Reports] |
|
|
|
| Wharton’s jelly-MSC-extracellylar vesicles (EVs) were isolated using Exo-Prep kit followed by characterization of expressing markers and size. After labeled by 111In-oxine, 111In-EVs were injected into C57BL/6 mice followed by μSPECT/CT imaging. Organs were then taken out for ex vivo biodistribution analysis. [Molecular Imaging and Biology] |
|
|
|
| Scientists report that overexpression of miR‐196b‐5p in Wharton’s jelly MSCs (WJCMSCs) suppressed proliferation and arrested the cell cycle in G0/G1 phase, whereas knock‐down of miR‐196b‐5p promotes WJCMSC proliferation and cell cycle progression. [Febs Open Bio] |
| |
|
|
|
| Investigators summarize pre-term white matter injury pathogenesis and pathophysiology, and the specific properties of different cell types in umbilical cord blood. [Journal of Neuroscience Research] |
|
|
|
|
| Be The Match BioTherapies as a preferred partner to provide consistent access to high-quality, healthy donor tissue and cell and gene therapy supply chain support. [Be The Match BioTherapies] |
|
|
|
|
| June 23 – June 26, 2021 Hamburg, Germany |
|
|
|
|
|
| University of Illinois at Chicago College of Medicine – Chicago, Illinois, United States |
|
|
|
| St. Jude Children’s Research Hospital – Memphis, Tennessee, United States |
|
|
|
| New York Blood Center – New York, New York, United States |
|
|
|
| Stanford University – Stanford, California, United States |
|
|
|
| United States Drug Testing Laboratories, Inc. – Des Plaines, Illinois, United States |
|
|
|
|